Rebalix
UBS · sheet of 10 September 2026
UBS · sheet of 10 September 2026ETF sheet · official issuer and register data
UBS Factor MSCI USA Prime Value Screened UCITS ETF hGBP dis
IE00BXDZNH00 · IE00BXDZNH00 · GBP · domicile Ireland
Equity · ValueGBP-hedged share classSFDR art. 8
Index tracked: MSCI USA Prime Value Advanced Target Select 100% Hedged to GBP Index (Net Total Return)
- TER
- 0.28%+ trans. 0.00%
- Fund size
- —
- Tracking difference
- +0.00%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Physical
- Income
- Distributingsemi-annual
Launch 1 Feb 2016 · costs from the KID as of 26 Aug 2026
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
Il Fondo è gestito in modo passivo e acquisirà un'esposizione proporzionale nelle componenti del MSCI USA Prime Value Advanced Target Select 100% Hedged to GBP Index (Net Total Return) tramite investimenti diretti in tutti o praticamente tutti i titoli e/o mediante l'impiego di strumenti derivati, in particolare nei casi in cui non è possibile o praticabile replicare l'indice attraverso investimenti diretti oppure allo scopo di generare efficienze nell'acquisizione di esposizione all'indice. In alcuni casi il comparto potrebbe anche detenere titoli non…
Performance since series start (in euro) — base 100
1 Feb 2016 → 8 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +16.5% |
| 3 years | +41.6% |
| 5 years | +42.5% |
| 10 years | +149.4% |
| Since series start | +163.6% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 12.54% | 13.74% | 15.74% |
| Max drawdown | −9.40% | −17.52% | −21.78% |
| Sharpe | 0.93 | 0.60 | 0.29 |
| Sortino | 1.40 | 0.89 | 0.42 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BXDZNH00 · IE00BXDZNH001
RebalixIE00BXDZNH00 · IE00BXDZNH00 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +11.93% | +11.95% | −0.02% |
| 2024 | +7.06% | +7.06% | +0.01% |
| 2023 | +13.84% | +13.83% | +0.01% |
| 2022 | −9.93% | −9.88% | −0.05% |
| 2021 | +27.99% | +28.10% | −0.11% |
Distributions · per share, in GBP
Frequency: semi-annual · last 12 months: 0.2264 GBP (1.14% of NAV) · last ex-date 13 Aug 2026
| Year | Payments | Total (GBP) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 0.2264 | — |
| 2025 | 2 | 0.1432 | +0.87% |
| 2024 | 2 | 0.2024 | +1.30% |
| 2023 | 2 | 0.2222 | +1.60% |
| 2022 | 2 | 0.2297 | +1.46% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BXDZNH00
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BXDZNH00
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IE00BXDZNH00 · IE00BXDZNH002